Publications by authors named "Zhenyu Mu"

Claim this Profile
C
Comprehensive investigation of a new signature integrating lipid metabolism and immune-related genes for clear cell renal cell carcinoma prognosis and immunometabolism landscapes.
Zhenyu Mu, Haizhu Fu, Shanchun Guo, Zhaoming Zhang, Zhiqiang Wang

Medicine (Baltimore)· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The efficacy and safety of immune checkpoint inhibitors in metastatic castration-resistant prostate cancer: A systematic review and meta-analysis.
Xing-Hui Wang, Zhi-Qiang Wang, Zhen-Yu Mu, Li-Ping Zhu, Chong-Fu Zhong

Medicine (Baltimore)· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunologic responses to xenogeneic tyrosinase DNA vaccine administered by electroporation in patients with malignant melanoma.
Jianda Yuan, Geoffrey Y Ku, Matthew Adamow, Zhenyu Mu, Sapna Tandon

J Immunother Cancer· May 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Enhancement of tumor-reactive cytotoxic CD4+ T cell responses after ipilimumab treatment in four advanced melanoma patients.
Shigehisa Kitano, Takemasa Tsuji, Caillian Liu, Daniel Hirschhorn-Cymerman, Chrisann Kyi, Zhenyu Mu

Cancer Immunol Res· October 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunological insights from patients undergoing surgery on ipilimumab for metastatic melanoma.
David E Gyorki, Jianda Yuan, Zhenyu Mu, Bushra Zaidi, Melissa Pulitzer

Ann Surg Oncol· September 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunologic correlates of the abscopal effect in a patient with melanoma.
Michael A Postow, Margaret K Callahan, Christopher A Barker, Yoshiya Yamada, Jianda Yuan, Zhenyu Mu, Samuel Rosner

N Engl J Med· March 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunologic response to xenogeneic gp100 DNA in melanoma patients: comparison of particle-mediated epidermal delivery with intramuscular injection.
Brian A Ginsberg, Humilidad F Gallardo, Teresa S Rasalan, Matthew Adamow, Zhenyu Mu

Clin Cancer Res· August 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correlation of clinical and immunological data in a metastatic melanoma patient with heterogeneous tumor responses to ipilimumab therapy.
Jianda Yuan, David B Page, Geoffrey Y Ku, Yanyun Li, Zhenyu Mu

Cancer Immun· January 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and immunogenicity of a human and mouse gp100 DNA vaccine in a phase I trial of patients with melanoma.
Jianda Yuan, Geoffrey Y Ku, Humilidad F Gallardo, Francesca Orlandi, Gregor Manukian, Zhenyu Mu

Cancer Immun· June 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mice that lack activity of alphavbeta6- and alphavbeta8-integrins reproduce the abnormalities of Tgfb1- and Tgfb3-null mice.
Poshala Aluwihare, Zhenyu Mu, Zhicheng Zhao, Dawen Yu, Paul H Weinreb, John S Munger

J Cell Sci· January 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
TGFbeta1 and TGFbeta3 are partially redundant effectors in brain vascular morphogenesis.
Zhenyu Mu, Zhiwei Yang, Dawen Yu, Zhicheng Zhao, John S Munger

Mech Dev· August 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Absence of integrin-mediated TGFbeta1 activation in vivo recapitulates the phenotype of TGFbeta1-null mice.
Zhiwei Yang, Zhenyu Mu, Branka Dabovic, Vladimir Jurukovski, Dawen Yu, John S Munger

J Cell Biol· March 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis